Delivery Order SPE2DB22D1017-SPE2DB25FE7LF

Award Date 10/17/24
Potential Completion Date 10/18/24
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FE7LF
    Delivery Order

This federal contract award, valued at $1,165.55, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,132,655 units of Losartan Potassium 100 mg tablets, a cardiovascular medication, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions.

The contract, which runs through October 18, 2024, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to the U.S. military and federal healthcare programs globally. There was no set-aside designation for this specific contract award.

Generated 1/16/25, 9:02 AM